Benign prostatic hyperplasia
(BPH) is non-cancerous cell gro-wth of the prostate gland.
When the prostate swells, whether because of benign prostatic hyperplasia
, prostate cancer, or prostatitis, it narrows the urethra, making it difficult for urine to pass freely from the bladder.
The report provides a snapshot of the global therapeutic landscape of Benign Prostatic Hyperplasia
American Urological Association Guideline: Management of Benign Prostatic Hyperplasia
(BPH) 2010: American Urological Association Education and Research, Inc;.
Detrusor instability is thought to occur in up to 40-60% of patients with benign prostatic hyperplasia
Difficulty urinating isn't always a sign of benign prostatic hyperplasia
Drugs that work through adrenergic receptors, such as Hytrin and Cardura, for benign prostatic hyperplasia
and hypertension, and Flomax for benign prostatic hyperplasia
, have been marketed successfully for a number of years.
Benign Prostatic Hyperplasia
Global Clinical Trials Review, H2, 2012" provides data on the Benign Prostatic Hyperplasia
clinical trial scenario.
Dutasteride Capsules are reportedly indicated as monotherapy for the treatment of symptomatic benign prostatic hyperplasia
(BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention and reduce the risk of the need for BPH-related surgery.
1] Approximately 50% of men over the age of 50 have histological benign prostatic hyperplasia
(BPH) and approximately 25% of men over 50 have moderate-to-severe LUTS.
The alpha adrenergic receptor system, which responds to the neurotransmitter adrenaline, is an important signaling mechanism in the body and is believed to be involved in such diverse therapeutic indications as cardiovascular disease, benign prostatic hyperplasia
, pain and glaucoma.
com/research/prhjrt/benign_prostatic) has announced the addition of Global Markets Direct's new report "Benign Prostatic Hyperplasia
- Pipeline Review, H2 2012" to their offering.